drugset / Trial / NCT01458054
Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults
RandomizedSingle-groupOpen-labelTreatment
Summary
This study is a Phase I open label drug interaction study to evaluate the effect of omeprazole and ritonavir on GSK2336805.
Timeline
- Start
- 2011-09-27
- Primary completion
- 2011-11-28
- Completion
- 2011-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK2336805 | Unknown | 30 mg | — |
| Subject | GSK2336805 | Unknown | 60 mg | — |
| Subject | Omeprazole | Other / unclassified | 40 mg | — |
| Subject | Ritonavir | Other / unclassified | 100 mg | — |